Crowdfunding for IPOs.

Access investment opportunities like the big end of town.


Successful Raisings


Capital Raised


OnMarket Crowd

Gain access

Now everyone can invest in IPOs. Get ASX IPOs delivered to your inbox. It’s never been easier to get fair, free access to IPOs.

Informed investing

View free digestible, relevant, research and video interviews with company management before deciding what to invest in.

Easy bidding process

Fast, simple, secure bidding into IPOs either via the OnMarket app or website. Buy shares directly from your phone.

Discover investment opportunities here

Tap 'More Info' to get access to free research, all company releases, and invest instantly for shares.

IPO Live

JYG Australia Ltd ASX: JYG

JYG Australia Ltd

JYG Australia Ltd (ASX: JYG) aims to be the leading professional services firm in Australia focusing on Asian in-bound capital. Taking a multidisciplinary approach, the Company advises on transactions for Asian investors by providing them with high quality accounting, legal and financial services without the top-tier price tag.  JYG Australia will target mid-sized transactions initiated by wealthy individuals and families and investors in small-to-medium enterprises.

$3.4 millionSize of Offer
19 Jan 18Offer Open
29 Jan 18Pay By
IPO OnMarket bidding closed

Simble Solutions Ltd ASX: SIS

Simble Solutions Ltd

Closing via OnMarket at 1pm today AEDT.

Payment must be made by 5pm Tuesday 23 January (AEDT) to avoid missing out

Simble Solutions Limited (ASX: SIS) is an Australian enterprise Software as a Service (SaaS) company focused on business and resource management. Its energy management solutions are principally catered towards enterprise and SME customers to reduce and manage their energy consumption. The platform is sold via channel partnerships in Australia, UK and NZ.

$6.5-7.5 millionSize of Offer
16 Jan 18Offer Open
23 Jan 18Pay By
IPO OnMarket Bidding Closed

Rong Yu Pharma. Ltd ASX: RY8

Rong Yu Pharma. Ltd

Applications for the Rong Yu Pharmaceuticals IPO have closed via OnMarket.  The company has extended the offer until 16 March.  

Rong Yu Pharmaceuticals Ltd (ASX RY8) was founded in 2004 and is focussed on the development, manufacture and sale of prescription and OTC pharmaceutical products based on principles of Traditional Chinese Medicine. With revenue of A$71.4 million in FY2017, the Company’s products are sold in 28 Provinces across China via a network of over 300 wholesale distributors.

$15-20 millionSize of Offer
28 Nov 17Offer Open
16 Mar 18Pay By

Performance of OnMarket IPOs and Placements

Our performance has motivated members to share OnMarket, earning them over $172,000 in rewards.

The average returns by days post-listing are...

1 day (75*)
1 Month (75*)
3 months (75*)
6 months (75*)

* Number of offers that have listed at the time of calculation. Figures as at 1 January 2018.

Performance figures are calculated using a simple average method.

See comprehensive breakdown of returns

See past transactions


OnMarket allows me to invest in companies that I want to see succeed and make an impact on the world, read my investor story


Refer OnMarket

Over $172,000 in reward payments so far

Join OnMarket

Refer OnMarket

Earn up to 25% of our selling fee

Start referring now